ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
98 272,22
0,06%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ventyx Biosciences Inc (VTYX)

  7. Ventyx Biosciences Inc (VTYX) Actualités

VTYX

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VTYX
DateHeureSourceTitreSymboleSociété
04/01/202500h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
27/12/202422h46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
18/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VTYXVentyx Biosciences Inc
15/11/202422h59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VTYXVentyx Biosciences Inc
07/11/202423h13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VTYXVentyx Biosciences Inc
07/11/202422h58Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
07/11/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
07/11/202422h05GlobeNewswire Inc.Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
15/10/202414h00GlobeNewswire Inc.Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024NASDAQ:VTYXVentyx Biosciences Inc
30/09/202422h40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VTYXVentyx Biosciences Inc
23/09/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces $27 Million Strategic Investment from SanofiNASDAQ:VTYXVentyx Biosciences Inc
09/09/202422h47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
06/09/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s DiseaseNASDAQ:VTYXVentyx Biosciences Inc
30/08/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces Departure of Chief Financial OfficerNASDAQ:VTYXVentyx Biosciences Inc
28/08/202414h00GlobeNewswire Inc.Ventyx Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
08/08/202422h01GlobeNewswire Inc.Ventyx Biosciences Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
29/07/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Participants with Moderately to Severely Active Crohn’s DiseaseNASDAQ:VTYXVentyx Biosciences Inc
05/06/202422h01GlobeNewswire Inc.Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory MarkersNASDAQ:VTYXVentyx Biosciences Inc
16/05/202422h05GlobeNewswire Inc.Ventyx Biosciences to Participate in Three Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
16/05/202414h00GlobeNewswire Inc.Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating OfficerNASDAQ:VTYXVentyx Biosciences Inc
09/05/202422h01GlobeNewswire Inc.Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
02/05/202422h05GlobeNewswire Inc.Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:VTYXVentyx Biosciences Inc
26/04/202411h45PR Newswire (US)The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYXNASDAQ:VTYXVentyx Biosciences Inc
19/04/202412h00PR Newswire (US)Ventyx Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYXNASDAQ:VTYXVentyx Biosciences Inc
16/04/202411h45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Biosciences, Inc. Lawsuit - VTYXNASDAQ:VTYXVentyx Biosciences Inc
09/04/202412h10PR Newswire (US)Investors in Ventyx Biosciences, Inc. Should Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYXNASDAQ:VTYXVentyx Biosciences Inc
05/04/202411h45PR Newswire (US)Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact The Gross Law Firm about pending Class Action - VTYXNASDAQ:VTYXVentyx Biosciences Inc
26/03/202410h45PR Newswire (US)Ventyx Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - VTYXNASDAQ:VTYXVentyx Biosciences Inc
11/03/202412h00GlobeNewswire Inc.Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor EventNASDAQ:VTYXVentyx Biosciences Inc
08/03/202422h05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VTYXVentyx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:VTYX

Dernières Valeurs Consultées

NYSE
MCD
McDonalds
NYSE
MRK
Merck
EU
EN
Bouygues
NYSE
NKE
Nike
EU
CS
Axa
COIN
XRPUSD
Ripple
COIN
DOGEUSD
Dogecoin
NASDAQ
GOOGL
Alphabet
NYSE
KO
Coca Cola
EU
RNO
Renault
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés